• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, December 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Lung Cancer: UVA health expert helps develop new national screening guidelines

Bioengineer by Bioengineer
March 30, 2021
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Revisions expand screening to more patients at high risk

IMAGE

Credit: UVA Health

Through his role on the U.S. Preventive Services Task Force, UVA Health’s Li Li, MD, PhD, MPH, has helped develop new lung cancer screening guidelines that expand screenings to more high-risk patients.

The new guidelines are focused on Americans at higher risk because of their history of smoking, which is the leading cause of lung cancer. There are two significant changes in the new guidelines. For those who are still smoking or quit less than 15 years ago, a yearly screening using a low-dose computed tomography (CT) scan is now recommended:

  • beginning at age 50, instead of age 55.
  • for anyone who has smoked 20 pack-years in their lifetime, instead of 30 pack-years. A pack-year equals smoking a pack of cigarettes a day for a year.

The new guidelines came following a review of the latest evidence of the benefits of lung cancer screening by Li and his colleagues on the Task Force, an independent, volunteer panel of national experts in prevention and evidence-based medicine. That evidence showed expanding the criteria would open screenings to more Black people and women, who data shows tend to smoke fewer cigarettes than white men.

“The new guidelines will have a tremendous impact on primary and secondary prevention of this dreadful cancer,” Li said. “It is a big step forward in reducing lung cancer disparities in Black people and women.”

Screenings are recommended for Americans ages 50 to 80 who meet the 20 pack-year criteria and are still smoking or quit less than 15 years ago. The Task Force recommends that current and former smokers who meet the updated criteria should discuss lung cancer screening with their doctor to determine whether the screening is right for them.

“Increasing the awareness and uptake of lung cancer screening, together with effective smoking cessation programs, are pressing priorities for UVA Health in its concerted effort to improve the health of residents in our region,” Li said.

###

More information about the recommendations is available at the Task Force’s website.

About the Task Force

The U.S. Preventive Services Task Force works to improve the health of people nationwide by making evidence-based recommendations about clinical preventive services, such as screenings, counseling services or preventive medicines. More information is available at http://www.uspreventiveservicestaskforce.org.

Media Contact
Eric Swensen
[email protected]

Original Source

https://newsroom.uvahealth.com/2021/03/30/uva-health-li-li-lung-cancer-screening-recommendations/

Related Journal Article

http://dx.doi.org/10.1001/jama.2021.1117

Tags: cancerCarcinogensHealth CareHealth Care Systems/ServicesHealth ProfessionalsMedicine/HealthPublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Metformin-Alogliptin Combo vs. Monotherapy in Diabetes

December 3, 2025

Botanical Extracts’ Antibacterial Activity Boosted by Enhancers

December 3, 2025

Global Guidelines for Shared Decision-Making in Valvular Heart Disease

December 3, 2025

Hidradenitis Suppurativa Remission Achieved Using Bacteriophage Therapy

December 3, 2025
Please login to join discussion

POPULAR NEWS

  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    204 shares
    Share 82 Tweet 51
  • Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    121 shares
    Share 48 Tweet 30
  • Neurological Impacts of COVID and MIS-C in Children

    107 shares
    Share 43 Tweet 27
  • MoCK2 Kinase Shapes Mitochondrial Dynamics in Rice Fungal Pathogen

    70 shares
    Share 28 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Boosting Cancer Immunotherapy by Targeting DNA Repair

Evaluating eGFR Equations in Chinese Children

Metformin-Alogliptin Combo vs. Monotherapy in Diabetes

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.